By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anthelmintics > Impavido
Anthelmintics

Impavido

https://themeditary.com/drug/impavido-2048.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: miltefosine [ mil-te-foe-seen ]

Drug class: Anthelmintics

Dosage form: capsule

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Miltefosine

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Impavido?

Impavido is an anti-parasitic drug used to treat leishmaniasis, a disease caused by an infection with parasites that enter the body through the bite of an infected sand fly.

Impavido is used to treat leishmaniasis affecting the skin, internal organs (such as the liver, spleen or bone marrow), and mucous membranes (nose, mouth, and throat).

Impavido may also be used for purposes not listed in this medication guide.

Warnings

In animal studies, Impavido has caused birth defects and death of unborn offspring. It is not known whether these effects would occur in people. You should not use miltefosine you are pregnant.

You may need to have a negative pregnancy test before starting this treatment. Use effective birth control while you are taking Impavido and for at least 5 months after your treatment ends.

How should I take Impavido

Take Impavido exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Take with food to lessen upset stomach.

Do not crush, chew, break, or dissolve a Impavido tablet. Swallow it whole.

Tell your doctor if you have any changes in weight. Miltefosine doses are based on weight (especially in children and teenagers), and any changes may affect the dose.

Vomiting or diarrhea can cause you to become dehydrated. This can lead to kidney failure while you are taking this medicine. Drink plenty of water each day while you are taking this medicine.

While using Impavido, you may need frequent blood tests. Your kidney function will need to be checked during treatment and for 4 weeks after you stop using this medicine.

Impavido is usually taken for 28 days in a row. Use this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared.

Store at room temperature away from moisture and heat. Keep each tablet in its blister pack until you are ready to take it.

Dosing information

Usual Adult Dose for Leishmaniasis:

-30 kg to 44 kg: 50 mg orally twice a day with food
-45 kg or greater: 50 mg orally three times a day with food
-Duration of therapy: 28 consecutive days

Detailed Impavido dosage information
Impavido Dosage information (more detail)

Before Taking

You should not use Impavido if you are allergic to miltefosine, or if you have:

  • a rare genetic skin and nerve disorder called Sjogren-Larsson syndrome; or

  • if you are pregnant.

To make sure Impavido is safe for you, tell your doctor if you have:

  • liver or kidney disease.

In animal studies, miltefosine caused birth defects and death of unborn offspring, and also affected fertility in male and female adults. It is not known whether these effects would occur in people using Impavido. Ask your doctor about your risk.

FDA pregnancy category D. You should not use Impavido if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control while you are taking Impavido and for at least 5 months after your treatment ends.

Vomiting or diarrhea caused by Impavido can make birth control pills less effective. Ask your doctor about using non hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy if you have vomiting and/or diarrhea while taking this medicine.

If you become pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of miltefosine on the baby.

It is not known whether miltefosine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine, and for at least 5 months after your treatment ends.

Impavido should not be given to a child younger than 12 years old.

Impavido pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Impavido?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Impavido side effects

Get emergency medical help if you have any of these signs of an allergic reaction to Impavido: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • severe or ongoing stomach problems (nausea, vomiting, diarrhea);

  • (in men) pain in the scrotum or testicles, abnormal ejaculation;

  • easy bruising or bleeding (nosebleeds, bleeding gums);

  • signs of a kidney problem--little or no urinating; painful or difficult urination; swelling in your feet or ankles; feeling tired or short of breath;

  • liver problems--nausea, upper stomach pain, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

  • severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Common Impavido side effects may include:

  • nausea, vomiting, stomach pain, loss of appetite;

  • diarrhea;

  • headache, dizziness, drowsiness; or

  • itching.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Impavido Side Effects

What other drugs will affect Impavido?

Other drugs may interact with miltefosine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

More about Impavido (Miltefosine [ mil-te-foe-seen ])

Dosage information
Impavido Side Effects
During pregnancy
Impavido Prescribing Information
Drug images
Side effects
Drug class: Anthelmintics

Related treatment guides

Leishmaniasis
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by